CANDELORO, Paola
 Distribuzione geografica
Continente #
NA - Nord America 597
AS - Asia 387
EU - Europa 377
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 34
AF - Africa 10
OC - Oceania 1
Totale 1.454
Nazione #
US - Stati Uniti d'America 580
SG - Singapore 193
IT - Italia 82
CN - Cina 79
IE - Irlanda 51
DE - Germania 49
HK - Hong Kong 46
RU - Federazione Russa 44
BR - Brasile 32
UA - Ucraina 27
SE - Svezia 26
FI - Finlandia 23
FR - Francia 21
VN - Vietnam 20
GB - Regno Unito 15
IN - India 14
ES - Italia 12
MX - Messico 9
AR - Argentina 8
BE - Belgio 8
PL - Polonia 6
CA - Canada 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
ID - Indonesia 4
KR - Corea 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
IQ - Iraq 3
TR - Turchia 3
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
JM - Giamaica 2
JP - Giappone 2
KE - Kenya 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
VE - Venezuela 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
IL - Israele 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
NG - Nigeria 1
NL - Olanda 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 1.420
Città #
Singapore 153
Chandler 88
San Jose 62
Dublin 51
Perugia 47
Hong Kong 46
Ann Arbor 41
Ashburn 32
Munich 32
San Mateo 28
Beijing 24
Santa Clara 20
Wilmington 18
Altamura 16
Boardman 16
Jacksonville 15
Medford 14
Moscow 14
Princeton 14
Lauterbourg 12
Lawrence 12
Helsinki 10
Ho Chi Minh City 10
Valencia 10
Los Angeles 9
Brussels 8
Frankfurt am Main 7
Juárez 6
New York 6
Redmond 6
Woodbridge 6
The Dalles 5
Atlanta 4
Brooklyn 4
Des Moines 4
Falls Church 4
Hanoi 4
Saint Petersburg 4
Seoul 4
Andover 3
Baku 3
Buenos Aires 3
Corridonia 3
Houston 3
Lucknow 3
Olomouc 3
Orem 3
Toronto 3
Turku 3
Amelia 2
Belo Horizonte 2
Bucu 2
Chicago 2
Dallas 2
Denver 2
Durban 2
Hyderabad 2
Osasco 2
Redwood City 2
Rouen 2
San Paolo di Civitate 2
Stockholm 2
Tashkent 2
Tokyo 2
Warsaw 2
Abuja 1
Agrolândia 1
Ahmedabad 1
Ankara 1
Araguaína 1
Arar 1
Arlington 1
Ashtabula 1
Astana 1
Asunción 1
Athens 1
Baghdad 1
Baoding 1
Barinas 1
Barueri 1
Birmingham 1
Bismarck 1
Bloomfield 1
Bloomington 1
Bogotá 1
Brasilândia de Minas 1
Brno 1
Cabo de Santo Agostinho 1
Camapuã 1
Campinas 1
Can Tho 1
Canal Winchester 1
Cape Coral 1
Cape Town 1
Capelinha 1
Capistrano 1
Caracas 1
Centro Municipality 1
Centurion 1
Changsha 1
Totale 963
Nome #
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 160
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 154
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 129
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 121
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 113
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 95
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 95
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 95
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 94
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 93
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 83
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 82
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 74
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 66
Totale 1.454
Categoria #
all - tutte 7.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.021


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022107 0 0 0 5 7 4 2 35 4 9 27 14
2022/2023234 15 45 7 27 20 28 0 8 74 0 7 3
2023/202494 6 8 5 1 2 0 18 0 4 3 34 13
2024/2025202 1 15 5 35 25 6 1 19 32 13 33 17
2025/2026501 37 20 32 26 88 26 100 28 86 36 18 4
2026/202772 51 13 8 0 0 0 0 0 0 0 0 0
Totale 1.454